Literature DB >> 12369952

Molecular modeling as a tool to investigate molecular recognition in P2Y receptors.

Stefano Moro1, Kenneth A Jacobson.   

Abstract

Nucleotides are emerging as an ubiquitous family of extracellular signaling molecules. These effects are mediated through a specific class of plasma membrane receptors called P2 receptors that, according to the molecular structure, are further subdivided into two subfamilies: P2Y and P2X. Specifically, P2X-receptors are ligand-gated ion channels, whereas P2Y-receptors belong to the superfamily of G-protein-coupled receptors. In this review, we focus our attention to GPCRs molecular architecture, with the special emphasis on our work on the human P2Y(1) receptor. In fact, despite an enormous amount of research on the structure and function of these receptors, fundamental understanding of the molecular details of ligand/GPCR interactions remains very rudimentary. How agonist binding transforms a resting GPCR into its active form and the microscopic basis of binding site blockade by an antagonist are generally still unclear. In the absence of high-resolution structural knowledge of GPCRs, such questions only can be addressed by building models, which are tested through pharmacological and biochemical studies. In this review, we underline how different molecular modeling approaches can help the investigation of both receptor architecture and ligand/receptor molecular recognition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12369952     DOI: 10.2174/1381612023392892

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  10 in total

Review 1.  G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.

Authors:  Kenneth A Jacobson; Ramachandran Balasubramanian; Francesca Deflorian; Zhan-Guo Gao
Journal:  Purinergic Signal       Date:  2012-02-29       Impact factor: 3.765

Review 2.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 3.  Agonists and antagonists for P2 receptors.

Authors:  Kenneth A Jacobson; Stefano Costanzi; Bhalchandra V Joshi; Pedro Besada; Dae Hong Shin; Hyojin Ko; Andrei A Ivanov; Liaman Mamedova
Journal:  Novartis Found Symp       Date:  2006

4.  Defining the nucleotide binding sites of P2Y receptors using rhodopsin-based homology modeling.

Authors:  Andrei A Ivanov; Stefano Costanzi; Kenneth A Jacobson
Journal:  J Comput Aided Mol Des       Date:  2006-10-03       Impact factor: 3.686

5.  Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands.

Authors:  Kevin Trujillo; Silvia Paoletta; Evgeny Kiselev; Kenneth A Jacobson
Journal:  Bioorg Med Chem       Date:  2015-03-21       Impact factor: 3.641

6.  Engineering of A3 Adenosine and P2Y Nucleotide Receptors and Their Ligands.

Authors:  Kenneth A Jacobson; Hak Sung Kim; Gnana Ravi; Soo-Kyung Kim; Kyeong Lee; Aishe Chen; Wangzhong Chen; Seong Gon Kim; Dov Barak; Bruce T Liang; Zhan-Guo Gao
Journal:  Drug Dev Res       Date:  2003-04       Impact factor: 5.004

7.  Molecular Structure of P2Y Receptors: Mutagenesis, Modeling, and Chemical Probes.

Authors:  Kenneth A Jacobson; M P Suresh Jayasekara; Stefano Costanzi
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-09-12

8.  A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist.

Authors:  Tali Fishman Jacob; Vijay Singh; Mudit Dixit; Tamar Ginsburg-Shmuel; Begoña Fonseca; Jesus Pintor; Moussa B H Youdim; Dan T Major; Orly Weinreb; Bilha Fischer
Journal:  Purinergic Signal       Date:  2018-07-17       Impact factor: 3.765

Review 9.  Progress in the pursuit of therapeutic adenosine receptor antagonists.

Authors:  Stefano Moro; Zhan-Guo Gao; Kenneth A Jacobson; Giampiero Spalluto
Journal:  Med Res Rev       Date:  2006-03       Impact factor: 12.388

10.  GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors.

Authors:  Chiara Parravicini; Graziella Ranghino; Maria P Abbracchio; Piercarlo Fantucci
Journal:  BMC Bioinformatics       Date:  2008-06-04       Impact factor: 3.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.